ST段抬高心肌梗死后随访护理与远程医疗观察研究数据表
STEMI患者疫情期间随访数据表，包含死亡率、再入院率、远程医疗使用及药物达标情况。
基本信息
资源简介
ST段抬高心肌梗死后随访护理与远程医疗观察研究数据表
【一句话概览】
本数据集是 figshare 公开的结构化表格数据集，收录 1 个文件、合计 13.81 KB，主题涵盖 COVID-19、telemedicine、telehealth、pandemic，可用于统计建模、特征工程与队列分析，CC BY 4.0 许可开放获取。
【数据集背景】
本数据集源站标题为《Table_1_Post-ST-Segment Elevation Myocardial Infarction Follow-Up Care During the COVID-19 Pandemic and the Possible Benefit of Telemedicine: An Observational Study.docx》。配套论文《The Impact of the COVID-19 Pandemic and the Importance of Telemedicine in Managing Acute ST Segment Elevation Myocardial Infarction Patients: Preliminary Experience and Literature Review》发表于 Journal of Medical Systems（2021），DOI：10.1007/s10916-020-01703-6。源站首次发布：2021-10-22。
【数据内容】
源站原始描述：Background: Infectious control measures during the COVID-19 pandemic have led to the propensity toward telemedicine. This study examined the impact of telemedicine during the pandemic on the long-term outcomes of ST-segment elevation myocardial infarction (STEMI) patients. Methods: This study included 288 patients admitted 1 year before the pandemic (October 2018–December 2018) and during the pandemic (January 2020–March 2020) eras, and survived their index STEMI admission. The follow-up period…
中文译文（机器翻译，仅供快速理解，请以原文为准）：背景：COVID-19疫情期间的感染控制措施推动了远程医疗的发展。本研究探讨了疫情期间远程医疗对ST段抬高型心肌梗死（STEMI）患者长期预后的影响。 方法：本研究纳入了在大流行前1年（2018年10月至2018年12月）及大流行期间（2020年1月至2020年3月）入院，并在其指数STEMI入院后存活的288例患者。随访期为1年。1年主要安全终点为全因死亡率。次要安全终点为因非计划血运重建、非致死性心肌梗死、心力衰竭、心律失常、不稳定型心绞痛而再次入院的心脏相关再入院。主要不良心血管事件（MACE）定义为各单项安全终点的复合结局。 结果：尽管与大流行前相比，大流行期间入院的患者院内结局更差，但两组1年全因死亡率相似（分别为11.2% vs. 8.5%，p = 0.454），但心脏相关（14.1% vs. 5.1%，p 结论：大流行促进了远程会诊的更广泛应用，并提高了对GDMT的依从性，改善了药物目标剂量达标情况。实现GDMT与良好的长期预后相关。
【数据结构与技术规格】
文件数 1 个，合计 13.81 KB。Table_1_Post-ST-Segment Elevation Myocardial Infarction Follow-Up Care During the COVID-19 Pandemic and the Possible Benefit of Telemedicine: An Obser.docx：application/vnd.openxmlformats-officedocument.wordprocessingml.document，13.81 KB。数据集 DOI：10.3389/fcvm.2021.755822.s001。
【主题与分类】
源站学科分类：Cardiology (incl. Cardiovascular Diseases)、Cardiology、Cardiorespiratory Medicine and Haematology not elsewhere classified。主题标签：COVID-19、telemedicine、telehealth、pandemic。
【适用方向】
结构化表格数据可直接用于统计建模、特征工程与队列分析。
【获取与许可】
源站页面：https://frontiersin.figshare.com/articles/dataset/Table_1_Post-ST-Segment_Elevation_Myocardial_Infarction_Follow-Up_Care_During_the_COVID-19_Pandemic_and_the_Possible_Benefit_of_Telemedicine_An_Observational_Study_docx/16851673
使用许可：CC BY 4.0（https://creativecommons.org/licenses/by/4.0/）。
规范引用：Zhang, Audrey A. Y.; Chew, Nicholas W. S.; Ng, Cheng Han; Phua, Kailun; Aye, Yin Nwe; Mai, Aaron; et al. (2021). Table_1_Post-ST-Segment Elevation Myocardial Infarction Follow-Up Care During the COVID-19 Pandemic and the Possible Benefit of Telemedicine: An Observational Study.docx. Frontiers. Datas…
【使用注意】
· 源站最后修改于 2023-05-30，引用时请注意版本时效。
下载信息
注册下载
需要注册 Kaggle 账号并登录后下载，适合需要跟踪下载记录和使用 API 的用户。
暂未开放公开下载
无需注册即可直接获取公开样本或文档，适合快速预览和评估数据集质量。
免登录有偿下载
公开数据集受托下载与技术交付服务。
提供高速下载与技术交付服务（收技术服务费，非数据销售）
暂未开放当前数据集主要来源为 Kaggle 公开托管，完整影像包建议通过原始链接或 Kaggle API 获取。
使用方式
数据集获取（Figshare）
- 源站标题：Table_1_Post-ST-Segment Elevation Myocardial Infarction Follow-Up Care During the COVID-19 Pandemic and the Possible Benefit of Telemedicine: An Observational Study.docx
- DOI：10.3389/fcvm.2021.755822.s001
- 发布日期：2021-10-22
- 文件数：1 个
- 文件总体积：13.81 KB
- 源站页面：https://frontiersin.figshare.com/articles/dataset/Table_1_Post-ST-Segment_Elevation_Myocardial_Infarction_Follow-Up_Care_During_the_COVID-19_Pandemic_and_the_Possible_Benefit_of_Telemedicine_An_Observational_Study_docx/16851673
命令行下载
curl -L -o "Table_1_Post-ST-Segment Elevation Myocardial Infarction Follow-Up Care During the COVID-19 Pandemic and the Possible Benefit of Telemedicine: An Obser.docx" "https://ndownloader.figshare.com/files/31155847"
文件清单
Table_1_Post-ST-Segment Elevation Myocardial Infarction Follow-Up Care During the COVID-19 Pandemic and the Possible Benefit of Telemedicine: An Obser.docx（13.81 KB）
文件总体积 13.81 KB（源站 API 实测）。
数据加载示例（图像类）
from PIL import Image
import glob, os
files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)
# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path) # 要求 子目录=类别
目录组织与标注格式以源站说明和下载后实际文件为准。
数据说明
Background: Infectious control measures during the COVID-19 pandemic have led to the propensity toward telemedicine. This study examined the impact of telemedicine during the pandemic on the long-term outcomes of ST-segment elevation myocardial infarction (STEMI) patients.
Methods: This study included 288 patients admitted 1 year before the pandemic (October 2018–December 2018) and during the pandemic (January 2020–March 2020) eras, and survived their index STEMI admission. The follow-up period was 1 year. One-year primary safety endpoint was all-cause mortality. Secondary safety endpoints were cardiac readmissions for unplanned revascularisation, non-fatal myocardial infarction, heart failure, arrythmia, unstable angina. Major adverse cardiovascular events (MACE) was defined as the composite outcome of each individual safety endpoint.
Results: Despite unfavorable in-hospital outcomes among patients admitted during the pandemic compared to pre-pandemic era, both groups had similar 1-year all-cause mortality (11.2 vs. 8.5%, respectively, p = 0.454) but higher cardiac-related (14.1 vs. 5.1%, p Conclusion: The pandemic has led to the wider application of teleconsultation, with increased adherence to GDMT, enhanced medication target dosing. Achieving GDMT was associated with favorable long-term prognosis.
许可
CC BY 4.0
引用
学术使用请引用 DOI 10.3389/fcvm.2021.755822.s001（source: https://frontiersin.figshare.com/articles/dataset/Table_1_Post-ST-Segment_Elevation_Myocardial_Infarction_Follow-Up_Care_During_the_COVID-19_Pandemic_and_the_Possible_Benefit_of_Telemedicine_An_Observational_Study_docx/16851673）。
数据缺失？
依托陕西、四川两大基地，我们与超过十家三甲医院建立直接合作关系，覆盖合规授权、采集治理、专业标注、数据交付的全流程，为AI医疗团队提供即拿即用的高质量临床数据。
⚡️ 需要数据支持或标注服务？立即联系我们获取专业方案。
